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Abstract
Magnesium (Mg) deficiency is a common nutritional disorder that is linked to an inflammatory state characterized by
increased plasma acute phase protein and proinflammatory cytokine concentrations. Recent studies have shown that
changes in the composition of gut microbiota composition participate in systemic inflammation. In this study, therefore,
we assessed the potential role of gut microbiota in intestinal and systemic inflammation associated with Mg deficiency in
mice. For this purpose, mice were fed a control or Mg-deficient diet (500 mg vs. 70 mg Mg/kg) for 4 or 21 d. Compared
with the mice fed the control diet, mice fed the Mg-deficient diet for 4 d had a lower gut bifidobacteria content (minus 1.5
log), a 36–50% lower mRNA content of factors controlling gut barrier function in the ileum (zonula occludens-1, occludin,
proglucagon), and a higher mRNA content (by;2-fold) in the liver and/or intestine of tumor necrosis factor-a, interleukin-6,
CCAAT/enhancer binding protein homologous protein, and activating transcription factor 4, reflecting inflammatory and
cellular stress. In contrast, mice fed theMg-deficient diet for 21 d had a higher cecal bifidobacteria content compared with
the control group, a phenomenon accompanied by restoration of the intestinal barrier and the absence of inflammation. In
conclusion, we show that Mg deficiency, independently of any other changes in nutrient intake, modulates the
concentration of bifidobacteria in the gut, a phenomenon that may time-dependently affect inflammation and metabolic
disorders in mice. J. Nutr. doi: 10.3945/jn.109.117374.
Introduction
Magnesium (Mg) is the second most abundant intracellular
cation after potassium and plays an essential role in numerous
fundamental cellular reactions (1). Mg deficiency is associated
with several metabolic disorders, including type 2 diabetes
(2,3), metabolic syndrome (4–6), dyslipidemia (7–9), and
hypertension (10–13). In addition, systemic inflammation has
been observed in subjects with hypomagnesemia (14,15). Gut
and systemic inflammation in rodent models of Mg deficiency
are characterized by leukocyte and macrophage activation with
increased production of inflammatory cytokines and acute
phase proteins (14,16,17). The mechanism underlying the
immunomodulation occurring during Mg deficiency remains
poorly described.
In our laboratory, we have demonstrated a link between gut
microbiota and systemic inflammation that drives the metabolic
disturbances in obesity (18–21). Lipopolysaccharide (LPS)7 is a
major component of the outer membrane of Gram-negative
bacteria, which, once in the circulation, can trigger the secretion
of proinflammatory cytokines (21,22). In several models of
obese mice, a decrease in cecal content of lactic acid-producing
bacteria, such as bifidobacteria, correlated with higher intestinal
permeability. Increased permeability promotes LPS transloca-
tion that drives endotoxemia and inflammation (19,20).
Therefore, in this study, we analyzed the intestinal and
systemic inflammatory response occurring in Mg-deficient mice
and related these data to changes in gut microbiota composition.
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Materials and Methods
Animals and diets.Male C57Bl/6J mice (9 wk old; Charles River) were
housed in groups of 4 mice per cage at 228C in a 12-h-light/-dark cycle
and given free access to diet and water.
After an acclimatization period of 1 wk, the mice (n = 8/group) were
fed a control (Mg+) (D10001, Research Diets) or a Mg-deficient diet
(Mg2) (D16601, Research Diets) for 4 or 21 d (Table 1). Distilled water
was provided for drinking. The Mg concentration was 500 mg/kg in the
control diet and 70 mg/kg in the deficient diet.
Food intake, taking into account spillage, was recorded daily during
the treatment as previously described (23,24).
All experiments were approved by the local animal ethics committee
and the housing conditions were as specified by the Belgian Law of
November 14, 1993 on the protection of laboratory animals (agreement
no. LA 1230314).
Tissue samples. At the end of the study period, mice were anesthetized
(ketamine/xylazine intraperitoneal, 100 and 10 mg/kg of body weight,
respectively). The liver was immediately clamped in liquid N2 and kept
at 2808C. Ileum tissue, proximal colon tissue, and cecal content were
collected and stored at 2808C. A fraction of ileum was washed with
PBS, mounted in embedding medium (Tissue-tek, Sakura), and stored at
2808C until use for immunofluorescence analysis. The jejunal mucosa
was scraped off and stored at 2808C. Liver, spleen, fatty tissues
(epididymal, subcutaneous, and visceral), cecal content, and cecal tissue
were weighed.
Blood samples. Portal vein blood was centrifuged 3 min at 13,0003 g
and stored at –80 8C. Serum LPS concentrations were determined using a
kit based on a Limulus amebocyte extract (LAL kit; Cambrex Biosci-
ence) as previously described (20); samples were diluted 1:100 in LPS-
free water. Cava vein blood was centrifuged 3 min at 13,000 3 g and
stored at –80 8C. The serum Mg concentration was determined using a
Quantichrom magnesium assay kit (DIMG-250 Bioassay Systems).
Disaccharidase activity. The jejunal sucrase, lactase, and maltase
activities were assessed in the jejunal mucosa following the method of
Dahlqvist (25).
Immunofluorescence analysis of occludin and ZO-1. The immu-
nofluorescence analysis of occludin (Occ) and zonula occludens-1
(ZO-1) in ileum was performed as previously described (20).
Real-time quantitative PCR. Total RNAwas isolated from liver tissue,
ileum, and proximal colon using the TriPure reagent (Roche). cDNAwas
prepared by RT of 1 g total RNA using the Kit Reverse transcription
System (Promega). Real-time PCR were performed with a StepOnePlus
instrument and software (Applied Biosystems) as described (19). RPL19
RNA was chosen as an invariant standard. Gene transcripts for tumor
necrosis factor-a (TNFa), interleukin (IL)-6, Occ, ZO-1, CCAAT/
enhancer binding protein homologous protein (CHOP), activating
transcription factor 4 (ATF4), CD68, F4/80, C-reactive protein (CRP),
IL-1b, and proglucagon (PG) were amplified using gene-specific primers
(Supplemental Table 1).
Real-time quantitative PCR for microbial cecal content. The cecal
contents of Gram-positive Bifidobacterium spp. and Lactobacillus spp.
were quantified as described previously (19). Results were expressed as
[Log10 (bacterial cells/g of cecal content)].
Statistical analysis. Results are presented as mean 6 SEM. Mg+ and
Mg2 mice were compared at each time using Student’s t-test with
GraphPad Prism version 4.00 for Windows. Associations between
variables were assessed by Pearson correlation test. P , 0.05 was
considered significant.
Results
Mg2 mice had a lower body weight than Mg+ mice after
21 d. We assessed Mg deficiency from the serum Mg concen-
tration. The serumMg levels in theMg2mice were 43 and 60%
lower than the corresponding control values after 4 and 21 d,
respectively (Table 2).
Mice fed a Mg-deficient diet for 4 d did not differ in food
intake or body weight compared with Mg+ mice, although
epididymal adipose tissue weight was ~22% lower (Table 2).
After 21 d, Mg2mice had lower body weight and white adipose
tissue mass than Mg+ mice. The progressive loss of fat mass and
body weight in the Mg2 mice may in part be explained by the
lower total energy intake observed in these mice during the 21 d
of the study period compared with Mg+ mice (Table 2).
Mg deficiency modulated gut microbiota. After 4 d, Mg2
mice had ~43% less cecal content of bifidobacteria compared
with Mg+ mice (Fig. 1A). The lactobacilli content did not differ
between the groups at d 4 (Fig. 1B). Cecal tissue and content
weight did not differ between Mg+ and Mg2 mice at d 4 (Table
2). Surprisingly, after 21 d, Mg2 mice had higher cecal tissue
and content weights (Table 2) and a higher intestinal content of
bifidobacteria and lactobacilli (Fig. 1C,D). The cecal content of
bacteroides did not differ betweenMg+ mice andMg- mice after
either 4 or 21 d (data not shown).
We measured the jejunal disaccharidase activity to assess
carbohydrate digestibility in the upper part of the intestine.
Jejunal lactase, maltase, and sucrase activities were lower in
Mg2 mice compared with Mg+ mice after 4 d (Supplemental
Fig. 1).
4 d of Mg deficiency induced colonic inflammation and
decreased factors controlling ileal permeability. After 4 d of
Mg deficiency, the expression of Occ and ZO-1, 2 tight junction
proteins, was ~37% less in the ileum of Mg2 compared with
Mg+ mice (Table 3). The immunofluorescence assay performed
on ileum sections of 4 d Mg+ mice revealed an intact network of
Occ and ZO-1 proteins that were predominantly localized along
TABLE 1 Composition of Mg+ and Mg2 diets
Ingredient Mg+ Mg2
composition, % kJ/kg diet composition, % kJ/kg diet
Casein 20 3349 20 3349
DL-Methionine 0.3 50 0.3 50
Corn starch 15 2512 15 2512
Sucrose 50 8374 50 8374
Cellulose, BW200 5 0 5 0
Corn oil 5 1884 5 1884
Mineral mix S100011 3.5 69 0 0
Mineral mix S166012 0 0 3.5 83
Vitamin mix V100013 1 167 1 167
Choline bitartrate 0.2 0 0.2 0
Total 100 16405 100 16419
1 Containing the following (g/kg mineral mix): 500 calcium phosphate, 24 magnesium
oxide, 220 potassium citrate.1H2O, 52 potassium sulphate, 74 sodium chloride, 0.55
chromium potassium sulphate.12H2O, 0.3 cupric carbonate, 0.01 potassium iodate, 6
ferric citrate, 3.5 manganous carbonate, 0.01 sodium selenite, 1.6 zinc carbonate, and
118 sucrose.
2 Containing the following (g/kg mineral mix): 500 calcium phosphate, 220 potassium
citrate.1H2O, 52 potassium sulphate, 74 sodium chloride, 0.55 chromium potassium
sulphate.12H2O, 0.3 cupric carbonate, 0.01 potassium iodate, 6 ferric citrate, 3.5
manganous carbonate, 0.01 sodium selenite, 1.6 zinc carbonate, and 142 sucrose.
3 Containing the following (g/kg vitamin mix): 0.8 retinol palmitate, 1 cholecalciferol,
10 dl-a tocopherol acetate, 0.05 mg menadione, 0.02 biotin, 0.001 cyanocobalamin,
0.2 folic acid, 3 nicotinic acid, 1.7 calcium pantothenate, 0.7 pyridoxine, 0.6 riboflavin,
0.6 thiamin, and 978.42 sucrose.
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the apical cellular border (Fig. 2A,C). On the contrary, 4 d Mg2
mice exhibited discontinuous ZO-1 and Occ staining in the
ileum (Fig. 2B,D). Similarly, Mg2 mice had ~ 50% lower ileal
content of PG mRNA, a precursor of glucagon-like peptide-2
that participates in the control of gut permeability (20,26–28).
These alterations were not associated with any sign of inflam-
mation or stress in the ileum. In fact, at d 4, Mg+ andMg2mice
did not differ in the ileal expression of TNFa and IL-6, 2
cytokines, or of ATF4 and CHOP, 2 markers of cellular stress
associated with the inflammatory process (Table 3). In contrast,
in the proximal colon of mice fed for 4 d with a Mg-deficient
diet, there were no differences in mRNA content of the genes
involved in intestinal permeability (PG, Occ, and ZO-1)
compared with Mg+ mice; however, there was a higher
expression of factors involved in cellular stress and inflamma-
tion (Table 3). CD68 and F4/80 expression, 2 markers of
monocyte infiltration, was similar in Mg+ and Mg2 mice in the
ileum and was 25–50% higher in the proximal colon of Mg2
mice compared with Mg+ mice (Table 3).
After 21 d of treatment, Mg+ and Mg2mice did not differ in
inflammation-related variables, monocyte infiltration, gut bar-
rier function, or metabolic stress in the ileum or in the proximal
colon (Table 3). Moreover, the immunofluorescence staining of
ZO-1 and Occ in the ileum sections was similar in Mg+ and
Mg2 mice after 21 d (Fig. 2E–H).
4 d of Mg deficiency induced systemic inflammation. Be-
cause the 4-d Mg deficiency induced systemic inflammation, we
assessed systemic inflammation. Mg2 mice tended to have
higher (P = 0.11) plasma LPS concentrations than did Mg+ mice
after 4 d (LPS: Mg+, 8.0 6 1.0 EU/L; Mg2, 12.2 6 2.1 EU/L).
The plasma LPS concentration did not differ between Mg+ and
Mg2mice after 21 d (LPS: Mg+, 8.96 3.5 EU/L; Mg2, 10.1 6
1.6 EU/L).
TABLE 2 Body and relative organs weight, energy intake, and serumMg in mice fed a Mg+ or Mg2 diet
for 4 or 21 d1
4 d of treatment 21 d of treatment
Mg+ Mg2 Mg+ Mg2
Body weight, g 22.89 6 0.35 22.79 6 0.41 23.79 6 0.53 21.92 6 0.40*
Spleen, g/100 g body weight 0.28 6 0.01 0.32 6 0.03 0.31 6 0.01 0.30 6 0.02
Liver, g/100 g body weight 3.64 6 0.12 3.87 6 0.08 3.91 6 0.10 3.59 6 0.08*
EAT,2 g/100 g body weight 1.74 6 0.10 1.36 6 0.11* 1.23 6 0.05 1.10 6 0.05
SAT,3 g/100 g body weight 0.95 6 0.05 0.95 6 0.12 1.44 6 0.06 1.33 6 0.06
VAT,4 g/100 g body weight 0.68 6 0.05 0.77 6 0.11 0.64 6 0.05 0.47 6 0.03*
Cecal tissue, g/100 g body weight 0.26 6 0.01 0.28 6 0.02 0.24 6 0.02 0.31 6 0.01*
Cecal content, g 0.11 6 0.01 0.14 6 0.01 0.13 6 0.02 0.17 6 0.01*
Total energy intake, kJ/mouse 160.02 6 4.06 143.27 6 9.38 953.84 6 27.80 793.82 6 6.32*
Serum Mg, mmol/L 0.79 6 0.03 0.45 6 0.06* 0.80 6 0.02 0.32 6 0.02*
1 Data are presented as mean 6 SEM, n = 8. *Different from Mg+, P , 0.05.
2 EAT, Epididymal adipose tissue.
3 SAT, Subcutaneous adipose tissue.
4 VAT, Visceral adipose tissue.
FIGURE 1 Cecal content of Bifidobacterium spp.,
and Lactobacillus spp. in mice fed a Mg+ or Mg2
diet for 4 d (A,B) or 21 d (C,D). Values are means 6
SEM, n = 8. *Different from Mg+, P , 0.05.
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After 4 d, Mg2 mice had a higher hepatic mRNA content of
IL-6 and TNFa than Mg+ mice (Fig. 3A). After 21 d, the hepatic
mRNA content of TNFa, IL-1b, CD68, and CRP did not differ
between Mg+ andMg2mice, except for significantly lower IL-6
mRNA content in Mg2 mice (Fig. 3B).
Bifidobacteria content correlated negatively with liver and
proximal colon markers of inflammation. Cecal bifidobac-
teria content correlated negatively with inflammatory markers in
the liver (IL-6: r = 20.65, P = 0.0003; TNFa: r = 20.44, P =
0.02) and in the proximal colon (IL-6: r = 20.42, P = 0.02;
TNFa: r =20.64, P = 0.0002) ofMg+ andMg2mice after 4 and
21 d.
Discussion
Several studies have described systemic inflammation in Mg-
deficient rodents, characterized by infiltration of leukocytes and
phagocytic cells in various tissues (such as heart, lung, skeletal
muscle, intestine, and thymus) and higher plasma levels of a
number of positive acute phase proteins and cytokines, such as
IL-6 and TNFa (14,29). However, a higher plasma TNFa
concentration has not always been observed during Mg
deficiency (17). Moreover, the mechanism underlying the
immunomodulation linked to Mg deficiency remains poorly
described.
In our laboratory, we have demonstrated a link between gut
microbiota and inflammation in several models of obesity
(20,30). The concentration of bifidobacteria correlated inversely
with endotoxemia, fat mass development, and disturbances in
glucose metabolism in high-fat–fed mice (18).
In this study, we show that the cecal content of bifidobacteria,
and to a lesser extent of lactobacilli, decreases during short-term
(4 d) Mg deficiency. This effect occurred independently of any
significant change in food intake and was therefore not attrib-
utable to any changes in other nutrients. Some studies have
revealed the importance of Mg in bifidobacteria physiology
(31,32). Mg requirements are much higher for Gram-positive
than for Gram-negative bacteria (33).
Interestingly, the concentrations of bifidobacteria and lacto-
bacilli were higher in Mg2 mice than in Mg+ mice after 21 d of
treatment. This phenomenon may be interpreted as an adaptive
mechanism. Despite a lower nutrient intake, Mg2 mice had a
greater cecal content and tissue weight than Mg+ mice at 21 d.
This observation suggests increased fermentation in Mg2 mice,
which could be explained by decreased activity of the intestinal
enzymes involved in carbohydrate digestion, leading to an
increased availability of nutrients in the ceco-colon for fermen-
tation. In fact, we observed reduced activity of the disaccharid-
ases in Mg2 mice compared with Mg+ mice.
Bifidobacteria are known to reduce intestinal LPS and to
improve mucosal barrier function (34–37). In our study, Mg2
mice had a lower cecal bifidobacteria content at d 4 than
Mg+ mice and this was associated with a lower ileal content of
ZO-1 and Occ mRNA, 2 tight junction proteins that control gut
barrier function. Analogous to the observation previously made
in obese animals (20), we can relate the decrease in ZO-1 and
Occ to a lower expression of PG in the ileum ofMg2mice at 4 d.
TABLE 3 mRNA levels of factors involved in gut barrier
function, inflammation, and cellular stress in
mice fed a Mg+ or Mg2 diet for 4 or 21 d1
4 d of treatment 21 d of treatment
Mg+ Mg2 Mg+ Mg2
Ileum relative expression
TNFa 1.09 6 0.18 1.05 6 0.31 1.06 6 0.17 0.67 6 0.13
IL-6 1.08 6 0.19 1.27 6 0.20 1.12 6 0.22 1.41 6 0.11
ATF4 1.01 6 0.06 0.98 6 0.05 1.02 6 0.09 1.21 6 0.13
CHOP 1.02 6 0.07 1.21 6 0.10 1.04 6 0.12 1.34 6 0.15
F4/80 1.03 6 0.09 0.84 6 0.11 1.00 6 0.20 1.24 6 0.15
CD68 1.02 6 0.09 0.99 6 0.18 1.05 6 0.13 1.11 6 0.10
Occ 1.03 6 0.10 0.64 6 0.06* 1.18 6 0.24 1.13 6 0.25
ZO-1 1.03 6 0.09 0.66 6 0.07* 1.18 6 0.24 1.27 6 0.22
PG 1.09 6 0.14 0.55 6 0.13* 1.24 6 0.34 1.39 6 0.46
Proximal colon
TNFa 1.25 6 0.31 3.00 6 0.39* 1.25 6 0.33 0.76 6 0.25
IL-6 1.03 6 0.11 3.03 6 0.68* 1.12 6 0.20 1.18 6 0.12
ATF4 1.02 6 0.07 1.34 6 0.07* 1.03 6 0.10 1.39 6 0.09
CHOP 1.05 6 0.12 1.64 6 0.13* 1.01 6 0.05 1.17 6 0.08
F4/80 1.01 6 0.06 1.51 6 0.18* 1.03 6 0.09 1.10 6 0.09
CD68 1.02 6 0.08 1.28 6 0.09* 1.00 6 0.03 1.11 6 0.09
Occ 1.06 6 0.13 1.15 6 0.18 1.09 6 0.18 0.98 6 0.10
ZO-1 1.05 6 0.12 1.25 6 0.13 1.06 6 0.14 0.97 6 0.07
PG 1.06 6 0.16 0.81 6 0.26 1.12 6 0.21 0.36 6 0.05*
1 Data are presented as mean 6 SEM, n = 8. *Different from Mg+, P , 0.05.
FIGURE 2 Immunofluorescence staining of the ileum epithelial tight
junction proteins in mice fed a Mg+ or Mg2 diet for 4 d (Occ: A,B;
ZO-1: C,D) or 21 d (Occ: E,F; ZO-1: G,H).
4 of 6 Pachikian et al.
PG mRNA is translated into glucagon-like peptide-2, an
intestinotrophic peptide that has been shown to decrease gut
permeability (26–28).
The higher intestinal permeability observed after 4 d of Mg
deficiency could explain the higher portal LPS concentration.
Systemic exposure to LPS is an important inflammatory trigger
(22) and is commonly associated with hepatic inflammation
(20). Chmielinska et al. (38) suggested the presence of increased
intestinal permeability in Mg-deficient rats. These investigators
described increased expression of the CD14 receptor, which
specifically binds LPS in the heart, gut, and liver tissue of Mg-
deficient rats.
Our results are in agreement with this previous observation,
because mice deficient inMg for 4 d had a higher mRNA content
of IL-6 and TNFa, 2 proinflammatory cytokines, in the liver
and in the proximal colon than control mice. Moreover, Mg2
mice exhibited a higher expression of CD68 and F4/80 in the
proximal colon, suggesting monocyte infiltration. Inflammation
is often accompanied by cellular alterations. Several reports have
demonstrated that inflammatory cytokines can induce endo-
plasmic reticulum stress and, therefore, activate the unfolded
protein response (39). Moreover, a study conducted in mice
demonstrated that LPS induced the expression of ATF4 and
CHOP in the lung (40). In the present study, the proximal colon
of Mg2 mice at 4 d, which exhibited a higher IL-6 and TNFa
mRNA content, also had a higher expression of stress markers,
such as ATF4 and CHOP, compared with Mg+ mice. The impact
of Mg deficiency on cellular and inflammatory stress seemed
confined to the proximal colon, because in the ileum, these
markers were not modified by Mg deficiency.
We can, therefore, suggest that decreased bifidobacteria
content as a result of short-term Mg deficiency may participate
in increased intestinal permeability, resulting in colonic and
systemic inflammation. Despite a progressive loss of body
weight, the mice fed a Mg-deficient diet for a longer period
had no signs of inflammation, in accordance with restoration of
gut microbiota composition (more bifidobacteria and lactoba-
cilli, less bacteroides).
In conclusion, we show that targeted nutritional modulation
of dietary mineral content (i.e. Mg level) may drive changes in
gut microbiota composition, which has consequences on host
metabolism.
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